Your browser doesn't support javascript.
loading
CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer.
Neesse, Albrecht; Frese, Kristopher K; Bapiro, Tashinga E; Nakagawa, Tomoaki; Sternlicht, Mark D; Seeley, Todd W; Pilarsky, Christian; Jodrell, Duncan I; Spong, Suzanne M; Tuveson, David A.
Affiliation
  • Neesse A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Proc Natl Acad Sci U S A ; 110(30): 12325-30, 2013 Jul 23.
Article in En | MEDLINE | ID: mdl-23836645
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal / Deoxycytidine / Connective Tissue Growth Factor / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Proc Natl Acad Sci U S A Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal / Deoxycytidine / Connective Tissue Growth Factor / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Proc Natl Acad Sci U S A Year: 2013 Document type: Article Affiliation country: Country of publication: